Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy

This study has been completed.
Information provided by:
Vasogen Identifier:
First received: May 26, 2005
Last updated: June 28, 2006
Last verified: June 2006